Close

Ald

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

L-alanine dehydrogenase catalyzes the reversible reductive amination of pyruvate to L-alanine. However, since the physiological environment of M.tuberculosis has a neutral pH, it can be assumed that the enzyme catalyzes exclusively the formation of L-alanine. L-alanine dehydrogenase may play a role in cell wall synthesis as L-alanine is an important constituent of the peptidoglycan layer.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0081 Human anti-Ald T cell receptor (AE7), pCDTCR1 Mycobacterium tuberculosis AE7 Human VLMGGVPGVE HLA-A*02:01 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0082 Human anti-Ald T cell receptor (AE8), pCDTCR1 Mycobacterium tuberculosis AE8 Human VLMGGVPGVE HLA-A*02:01 Lentiviral vector   Add to Cart   Datasheet
TCR-YC0083 Human anti-Ald T cell receptor (VD3), pCDTCR1 Mycobacterium tuberculosis VD3 Human VLMGGVPGVE HLA-A*02:01 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.